ELISA NephroSant Readies Launch of Kidney Transplant Rejection Assay Premium Following the launch of its urine-based Qsant assay later this year, the firm plans to develop updated versions of it with new biomarkers for different disease indications. Biodesix Prices $72M IPO Shares of the Boulder, Colorado-based firm will begin trading on the Nasdaq today under ticker symbol "BDSX" at $18 per share. McGill Spinout Nplex Launching Highly Multiplexed ELISA System Next Year Premium The firm uses a miniaturized, bead-based-ELISA format to multiplex hundreds to thousands of immunoassays rapidly and without antibody cross-reactivity. Nephrosant Eyes Launch of Urine-Based Kidney Transplantation Rejection Risk Assay Premium The San Francisco-based startup believes that its QiSant assay could help guide the use of immunosuppressive drugs and other therapies to prevent kidney transplant rejection. Startup Nephrosant Aims to Launch Noninvasive Kidney Transplantation Test by Early 2020 Premium The UCSF spinout aims to develop noninvasive tests to detect kidney injury for the transplantation field and to diagnose and monitor chronic disease. Breaking News Illumina, Kartos Therapeutics Partner to Develop TP53 Companion Diagnostic Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies Medicare Administrative Contractor Palmetto Finalizes Coverage of Molecular Testing for Organ Transplant Rejection 23andMe Team Sees Genetic, Nongenetic Contributors to COVID-19 Risk in Trans-Ancestry Study Todos Medical Acquires Provista Diagnostics for $7.5M Renalytix AI Lands US Government Contract for Kidney Disease Test The Scan Not Kept "Clean and Sanitary" A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports. Resumption Recommendation Expected The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine. Canada's New Budget on Science Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research. Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.